Thursday November 26 2009 | Biotechnology feed | All feeds
|
|
Naryx Pharma, Inc.
Download detailed PDF Members: Naryx Pharma is a specialty pharmaceutical company that is developing promising propriety medication formulations for the FDA approval process. Naryx Pharma is focused on development of its product candidates of inhaled, nebulized, intranasal drug formulations. The approvals will enable Naryx Pharma to market and distribute formulations that will fulfill an unmet medical need for the treatment of patients with chronic rhinosinusitis (CRS). The Company believes that the eventual approval of such formulations by the FDA will lead to an important new avenue in the standard of care for treating CRS, the largest chronic disease afflicting in excess of 29 million adult Americans. The Company has been issued a U.S. patent for the drug compositions and has several other patents pending related to CRS.
This page has been viewed 915 times since April 2007, the link to the organisation's website has been followed 226 times Recent Search Terms used to find this page: naryx pharmaceuticals | naryx pharma inc. website | naryx logo | Naryx Pharma Inc contact us | naryx address | NARYX PHARMACEUTICALS | naryx pharma inc san diego ca | naryx | Naryx Pharmaceuticals | Michael Narachi | . Search for more companies in Carpinteria Search for more companies in California This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified. BioPortfolio search results for Naryx Pharma, Inc. | |||||||||||||||||||||||||||||||||||||||||||||||||
|